Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to Sell at StockNews.com
StockNews.com upgraded shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Get Rating) to a sell rating in a research note issued to investors on Friday. A number of other research analysts also recently issued reports on SNDX. Citigroup raised their price target on Syndax Pharmaceuticals from $29.00 to $32.00 and gave the stock a buy rating in […]